ChemicalBook >> CAS DataBase List >>FerroLOXIN-1

FerroLOXIN-1

CAS No.
2773428-48-9
Chemical Name:
FerroLOXIN-1
Synonyms
FerroLOXIN-1;1H-Imidazol-2-amine, 1-(3-fluorophenyl)-N-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]-4-phenyl-
CBNumber:
CB115239386
Molecular Formula:
C23H16F5N3
Molecular Weight:
429.39
MDL Number:
MOL File:
2773428-48-9.mol
MSDS File:
SDS
Last updated:2026-01-13 11:14:13

FerroLOXIN-1 Properties

Boiling point 556.620±60.00 °C(Press: 760.00 Torr)(predicted)
Density 1.307±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
storage temp. -10 to -25°C
solubility DMSO: 2mg/mL, clear (Warmed)
form powder
pka 7.141±0.10(predicted)
color white to beige
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

WGK Germany  WGK 3
Storage Class 11 - Combustible Solids

FerroLOXIN-1 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 39325 FerroLOXIN-1 ≥90% 2773428-48-9 1mg $32 2026-04-30 Buy
Cayman Chemical 39325 FerroLOXIN-1 ≥90% 2773428-48-9 5mg $152 2026-04-30 Buy
Cayman Chemical 39325 FerroLOXIN-1 ≥90% 2773428-48-9 10mg $288 2026-04-30 Buy
Product number Packaging Price Buy
39325 1mg $32 Buy
39325 5mg $152 Buy
39325 10mg $288 Buy

FerroLOXIN-1 Chemical Properties,Uses,Production

Uses

FerroLOXIN-1 is a potent inhibitor of 15LOX-2 that selectively blocked production of pro-ferroptotic HOO-ETE-PE and protected against RSL3-induced ferroptosis. FerroLOXIN-1 closely interacted therein with 15LOX-2 only, and in particular with Y154, N155, W158[1].

Biological Activity

15LOX/PEBP1 catalytic complex inhibitor th at prevents cell death by ferroptosis, but not necroptosis, pyroptosis, or apoptosis.


FerroLOXIN-1 is a ferroptosis inhibitor th at selectively targets the 15LOX/PEBP1 catalytic complex without affecting the biosynthesis of pro-/anti-inflammatory lipid mediators. FerroLOXIN-1 prevents 0.5 μM GPX4 inhibitor RSL3-induced ferroptosis in HBE cell cultures (IC50 = 84 nM post 20h RSL3 treatment) and rescues mice from total body irradiation (TBI)-induced death in vivo (Cpd administered via 25 mg/kg ip. 20h post 9.25Gy irradiation; survival on day 27 = 75% vs. 0% on day 19 of untreated control). FerroLOXIN-1 does not exert its efficacy via radical scavenging or iron-chelating activity, nor does it prevent cell death by necroptosis, pyroptosis, or apoptosis.

IC 50

5-LOX

References

[1] Dong J, et al. Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy. Angew Chem Int Ed Engl. 2023 May 22;62(22):e202303818.

FerroLOXIN-1 Preparation Products And Raw materials

Raw materials

Preparation Products

FerroLOXIN-1 Suppliers

Global( 6)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Beckham Medical Technology Co., Ltd 13816613772 huahero21@sina.com China 2996 55
TargetMol 400-821-0310 15002144251 xuexiang.shao@tsbiochem.com China 29128 58
FerroLOXIN-1 1H-Imidazol-2-amine, 1-(3-fluorophenyl)-N-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]-4-phenyl- 2773428-48-9